Company intelligence / Profile preview

Constant Therapy Health

Newton, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Constant Therapy has completed 140 million exercises with users. A decentralized Phase II clinical trial showed statistically and clinically more significant effectiveness than standard care for post-stroke aphasia treatment. A pilot with Burke Rehabilitation demonstrated more than half of participants achieved statistically significant gains, with average improvement of 8.9 points on the Western Aphasia Battery-Revised (WAB-R).

Therapeutic areas: Neurology
Modalities: Non-pharmacological therapyDigital therapeutic
Industry: Digital Health Medical Devices

Partnerships

Elara Caring (AI-driven speech-language and cognitive therapy at scale)Burke Rehabilitation (outpatient speech therapy program for stroke and neurological conditions)

Beyond the preview

Go deeper on Constant Therapy Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Constant Therapy Health.

Explore the full profile